Literature DB >> 9259432

Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis.

M Mannik1, M H Wener.   

Abstract

OBJECTIVE: To determine if antibodies to the collagen-like region of C1q (C1q-CLR) are present in the glomerular immune deposits of patients with systemic lupus erythematosus (SLE).
METHODS: Kidney tissues were obtained at autopsy, glomeruli were isolated, and glomerular basement membrane fragments were prepared. Antibodies were extracted with low pH or with DNase.
RESULTS: The concentrations of antibodies to C1q-CLR recovered from the glomeruli were > or =50-fold higher per unit of IgG than that found in the serum or in the serum and interstitial fluid entrained in glomeruli. Antibodies to C1q-CLR were recovered from glomeruli of 4 of 5 patients with proliferative glomerulonephritis at autopsy.
CONCLUSION: This is the first demonstration that antibodies to C1q-CLR are deposited and concentrated in the renal glomeruli of patients with SLE. These antibodies, thus, have the potential of contributing to the pathogenesis of lupus glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259432     DOI: 10.1002/art.1780400819

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

1.  Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.

Authors:  Maurizio Bruschi; Maricla Galetti; Renato Alberto Sinico; Gabriella Moroni; Alice Bonanni; Antonella Radice; Angela Tincani; Federico Pratesi; Paola Migliorini; Corrado Murtas; Franco Franceschini; Barbara Trezzi; Francesca Brunini; Rita Gatti; Regina Tardanico; Giancarlo Barbano; Giorgio Piaggio; Piergiorgio Messa; Pietro Ravani; Francesco Scolari; Giovanni Candiano; Alberto Martini; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

Review 2.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis.

Authors:  Zhu Chen; Guo-Sheng Wang; Gui-Hong Wang; Xiang-Pei Li
Journal:  Clin Rheumatol       Date:  2012-06-14       Impact factor: 2.980

Review 4.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 5.  Are anti-C1q antibodies different from other SLE autoantibodies?

Authors:  Matthew C Pickering; Marina Botto
Journal:  Nat Rev Rheumatol       Date:  2010-04-27       Impact factor: 20.543

Review 6.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

7.  Anti-C1q autoantibodies in murine lupus nephritis.

Authors:  L A Trouw; M A Seelen; R Visseren; J M G J Duijs; H Benediktsson; E de Heer; A Roos; C van Kooten; M R Daha
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

8.  Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.

Authors:  V Michael Holers
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

Authors:  Leendert A Trouw; Tom W L Groeneveld; Marc A Seelen; Jacques M G J Duijs; Ingeborg M Bajema; Frans A Prins; Uday Kishore; David J Salant; J Sjef Verbeek; Cees van Kooten; Mohamed R Daha
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.

Authors:  N Marto; M L Bertolaccini; E Calabuig; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.